https://www.selleckchem.com/pr....oducts/emd-1214063.h
Part II Ten cats participated in the study. Potassium values were significantly lower in cats receiving dorzolamide 2% ophthalmic solution compared to placebo at each time point throughout the 6-week study period. Additionally, chloride values were significantly greater in the treatment group at week two and four compared to the placebo group. Administration of dorzolamide 2% ophthalmic solution has a measurable effect on serum potassium level in cats and may result in clinical hypokalemia. Therefore, routine electrolyte monitoring